543 related articles for article (PubMed ID: 33934365)
41. The prognostic significance of combined ERG and androgen receptor expression in patients with prostate cancer managed by androgen deprivation therapy.
Huang KC; Alshalalfa M; Hegazy SA; Dolph M; Donnelly B; Bismar TA
Cancer Biol Ther; 2014 Sep; 15(9):1120-8. PubMed ID: 24972028
[TBL] [Abstract][Full Text] [Related]
42. Probing the tumorigenic potential of genetic interactions reconstituted in murine fallopian tube organoids.
Maru Y; Tanaka N; Tatsumi Y; Nakamura Y; Yao R; Noda T; Itami M; Hippo Y
J Pathol; 2021 Oct; 255(2):177-189. PubMed ID: 34184756
[TBL] [Abstract][Full Text] [Related]
43. Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors that Can Function as a Cell of Origin for Prostate Cancer.
Zhang D; Lin K; Lu Y; Rycaj K; Zhong Y; Chao HP; Calhoun-Davis T; Shen J; Tang DG
Stem Cells Transl Med; 2017 Mar; 6(3):748-760. PubMed ID: 28297567
[TBL] [Abstract][Full Text] [Related]
44. Development of a system combining comprehensive genotyping and organoid cultures for identifying and testing genotype-oriented personalised medicine for pancreatobiliary cancers.
Shiihara M; Ishikawa T; Saiki Y; Omori Y; Hirose K; Fukushige S; Ikari N; Higuchi R; Yamamoto M; Morikawa T; Nakagawa K; Hayashi H; Mizuma M; Ohtsuka H; Motoi F; Unno M; Okamura Y; Kinoshita K; Furukawa T
Eur J Cancer; 2021 May; 148():239-250. PubMed ID: 33752134
[TBL] [Abstract][Full Text] [Related]
45. Organoid technology in cancer precision medicine.
Xia X; Li F; He J; Aji R; Gao D
Cancer Lett; 2019 Aug; 457():20-27. PubMed ID: 31078736
[TBL] [Abstract][Full Text] [Related]
46. A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids.
Senkowski W; Gall-Mas L; Falco MM; Li Y; Lavikka K; Kriegbaum MC; Oikkonen J; Bulanova D; Pietras EJ; Voßgröne K; Chen YJ; Erkan EP; Dai J; Lundgren A; Grønning Høg MK; Larsen IM; Lamminen T; Kaipio K; Huvila J; Virtanen A; Engelholm L; Christiansen P; Santoni-Rugiu E; Huhtinen K; Carpén O; Hynninen J; Hautaniemi S; Vähärautio A; Wennerberg K
Dev Cell; 2023 Jun; 58(12):1106-1121.e7. PubMed ID: 37148882
[TBL] [Abstract][Full Text] [Related]
47. Organoids: Construction and Application in Gastric Cancer.
Huo C; Zhang X; Gu Y; Wang D; Zhang S; Liu T; Li Y; He W
Biomolecules; 2023 May; 13(5):. PubMed ID: 37238742
[TBL] [Abstract][Full Text] [Related]
48. Microfluidic droplet encapsulation-guided organoid growth promotes parental tumor phenotype recapitulation.
Zhang W; Jin H; Lou S; Yang H; Dai X; Ma S
Int J Cancer; 2024 Jan; 154(1):145-154. PubMed ID: 37622267
[TBL] [Abstract][Full Text] [Related]
49. Early Cell Cultures from Prostate Cancer Tissue Express Tissue Specific Epithelial and Cancer Markers.
Ryabov VM; Baryshev MM; Voskresenskiy MA; Popov BV
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769153
[TBL] [Abstract][Full Text] [Related]
50. Establishment of patient-derived cancer organoids for drug-screening applications.
Driehuis E; Kretzschmar K; Clevers H
Nat Protoc; 2020 Oct; 15(10):3380-3409. PubMed ID: 32929210
[TBL] [Abstract][Full Text] [Related]
51. Establishment of 2.5D organoid culture model using 3D bladder cancer organoid culture.
Abugomaa A; Elbadawy M; Yamanaka M; Goto Y; Hayashi K; Mori T; Uchide T; Azakami D; Fukushima R; Yoshida T; Shibutani M; Yamashita R; Kobayashi M; Yamawaki H; Shinohara Y; Kaneda M; Usui T; Sasaki K
Sci Rep; 2020 Jun; 10(1):9393. PubMed ID: 32523078
[TBL] [Abstract][Full Text] [Related]
52. Generation of ductal organoids from normal mammary luminal cells reveals invasive potential.
Ganz HM; Buchmann B; Engelbrecht LK; Jesinghaus M; Eichelberger L; Gabka CJ; Schmidt GP; Muckenhuber A; Weichert W; Bausch AR; Scheel CH
J Pathol; 2021 Dec; 255(4):451-463. PubMed ID: 34467523
[TBL] [Abstract][Full Text] [Related]
53. Newly established patient-derived organoid model of intracranial meningioma.
Yamazaki S; Ohka F; Hirano M; Shiraki Y; Motomura K; Tanahashi K; Tsujiuchi T; Motomura A; Aoki K; Shinjo K; Murofushi Y; Kitano Y; Maeda S; Kato A; Shimizu H; Yamaguchi J; Adilijiang A; Wakabayashi T; Saito R; Enomoto A; Kondo Y; Natsume A
Neuro Oncol; 2021 Nov; 23(11):1936-1948. PubMed ID: 34214169
[TBL] [Abstract][Full Text] [Related]
54. An Organoid Assay for Long-Term Maintenance and Propagation of Mouse Prostate Luminal Epithelial Progenitors and Cancer Cells.
Shu Y; Chua CW
Methods Mol Biol; 2019; 1940():231-254. PubMed ID: 30788830
[TBL] [Abstract][Full Text] [Related]
55. Next-Generation Modeling of Cancer Using Organoids.
Love JR; Karthaus WR
Cold Spring Harb Perspect Med; 2024 Jun; 14(6):. PubMed ID: 37734867
[TBL] [Abstract][Full Text] [Related]
56. Generation and Culture of Human Pancreatic Ductal Adenocarcinoma Organoids from Resected Tumor Specimens.
Baker LA; Tiriac H; Tuveson DA
Methods Mol Biol; 2019; 1882():97-115. PubMed ID: 30378047
[TBL] [Abstract][Full Text] [Related]
57. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
[TBL] [Abstract][Full Text] [Related]
58. Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study.
Votanopoulos KI; Mazzocchi A; Sivakumar H; Forsythe S; Aleman J; Levine EA; Skardal A
Ann Surg Oncol; 2019 Jan; 26(1):139-147. PubMed ID: 30414038
[TBL] [Abstract][Full Text] [Related]
59. Establishment and Maintenance of Human CRC-Derived Organoids for PcG Studies.
Della Chiara G; Pagani M
Methods Mol Biol; 2023; 2655():231-244. PubMed ID: 37213001
[TBL] [Abstract][Full Text] [Related]
60. Cancer organoids: A platform in basic and translational research.
Ma X; Wang Q; Li G; Li H; Xu S; Pang D
Genes Dis; 2024 Mar; 11(2):614-632. PubMed ID: 37692477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
